Personal tools

MCL coexpression mm9:235: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0000073!1.08e-30!54;UBERON:0001049!9.46e-30!52;UBERON:0005068!9.46e-30!52;UBERON:0006241!9.46e-30!52;UBERON:0007135!9.46e-30!52;UBERON:0002020!9.15e-28!34;UBERON:0000955!4.46e-25!47;UBERON:0006238!4.46e-25!47;UBERON:0001017!3.44e-24!73;UBERON:0002616!1.93e-23!46;UBERON:0001016!2.52e-23!75;UBERON:0003528!6.88e-23!29;UBERON:0002791!6.88e-23!29;UBERON:0001893!6.88e-23!29;UBERON:0002346!9.80e-23!64;UBERON:0003075!9.80e-23!64;UBERON:0007284!9.80e-23!64;UBERON:0003080!2.80e-21!40;UBERON:0002021!4.75e-21!10;UBERON:0000411!4.75e-21!10;UBERON:0001950!4.75e-21!10;UBERON:0002780!7.82e-20!39;UBERON:0001890!7.82e-20!39;UBERON:0006240!7.82e-20!39;UBERON:0002619!2.35e-19!17;UBERON:0010371!5.42e-19!73;UBERON:0000956!8.72e-18!21;UBERON:0001869!8.72e-18!21;UBERON:0000203!8.72e-18!21;UBERON:0004121!1.09e-16!95;UBERON:0000924!1.09e-16!95;UBERON:0006601!1.09e-16!95;UBERON:0003056!2.74e-16!49;UBERON:0010314!1.64e-13!92;UBERON:0000025!1.76e-09!114;UBERON:0003076!7.27e-09!12;UBERON:0003057!7.27e-09!12;UBERON:0004111!2.20e-08!122;UBERON:0002950!2.22e-08!4;UBERON:0001891!2.22e-08!4;UBERON:0009616!2.22e-08!4;UBERON:0010286!2.22e-08!4;UBERON:0002240!1.29e-07!6;UBERON:0005174!1.29e-07!6;UBERON:0001137!1.29e-07!6
|ontology_enrichment_uberon=UBERON:0000073!1.08e-30!54;UBERON:0001049!9.46e-30!52;UBERON:0005068!9.46e-30!52;UBERON:0006241!9.46e-30!52;UBERON:0007135!9.46e-30!52;UBERON:0002020!9.15e-28!34;UBERON:0000955!4.46e-25!47;UBERON:0006238!4.46e-25!47;UBERON:0001017!3.44e-24!73;UBERON:0002616!1.93e-23!46;UBERON:0001016!2.52e-23!75;UBERON:0003528!6.88e-23!29;UBERON:0002791!6.88e-23!29;UBERON:0001893!6.88e-23!29;UBERON:0002346!9.80e-23!64;UBERON:0003075!9.80e-23!64;UBERON:0007284!9.80e-23!64;UBERON:0003080!2.80e-21!40;UBERON:0002021!4.75e-21!10;UBERON:0000411!4.75e-21!10;UBERON:0001950!4.75e-21!10;UBERON:0002780!7.82e-20!39;UBERON:0001890!7.82e-20!39;UBERON:0006240!7.82e-20!39;UBERON:0002619!2.35e-19!17;UBERON:0010371!5.42e-19!73;UBERON:0000956!8.72e-18!21;UBERON:0001869!8.72e-18!21;UBERON:0000203!8.72e-18!21;UBERON:0004121!1.09e-16!95;UBERON:0000924!1.09e-16!95;UBERON:0006601!1.09e-16!95;UBERON:0003056!2.74e-16!49;UBERON:0010314!1.64e-13!92;UBERON:0000025!1.76e-09!114;UBERON:0003076!7.27e-09!12;UBERON:0003057!7.27e-09!12;UBERON:0004111!2.20e-08!122;UBERON:0002950!2.22e-08!4;UBERON:0001891!2.22e-08!4;UBERON:0009616!2.22e-08!4;UBERON:0010286!2.22e-08!4;UBERON:0002240!1.29e-07!6;UBERON:0005174!1.29e-07!6;UBERON:0001137!1.29e-07!6
|tfbs_overrepresentation_for_novel_motifs=0.683155,1.12894,0.144471,0.213815,0.158125,0.497287,0.341805,0.0576812,0.450182,1.41534,0.285618,0.326048,0.875309,1.19222,0.355805,0,0.64442,0.147843,0.0469139,0.453931,0.27166,1.11445,0.110607,0.0119755,0.151545,0.789837,0.333756,1.91266,0.222987,0.204382,0.877117,0.299728,0.144991,0.271358,1.24274,0.581004,1.38214,0.321367,0.108318,0.752803,0.152868,0.243838,0.0776733,0.0704931,1.03978,0.444935,0.520226,0.273217,0.223484,0.227531,1.1586,0.854405,0.186365,1.05744,0.425236,0.367773,0.241541,0.309628,0.304202,0.736988,0.284859,0.447183,0.167995,0.207938,0.120577,0.663331,0.541105,0.859836,0.281425,0.722621,0.302198,0.0623436,5.72176,0.453125,0.0811907,0.141357,0.850508,0.168288,0.272308,0.115828,0.144565,0.239205,0.144928,0.0528752,0.359152,0.0482209,3.07062,0.925885,0.178324,1.01435,0.602595,0.952616,0.309353,0.330603,9.11382,0.339568,0.245602,0.311476,1.00037,1.54559,0.0482794,0.299519,1.02647,0.617549,0.215126,0.0690786,0.256395,0.26834,0.119914,0.274655,1.02853,0.398154,1.20233,0.292039,0.608883,0.303976,0.449486,0.475191,0.228131,0.266226,0.457657,1.07576,0.126502,0.501766,0.657577,0.274996,0.352633,0.304247,0.539782,0.337513,0.383004,0.205841,0.514133,0.386419,0.628232,3.6718,0.178072,0.525553,0.584355,1.37293,0.983786,0.545219,0.415128,0.30759,0.210806,0.244366,0.177215,1.33397,0.180481,1.53238,0.211243,5.08225,0.412186,0.199012,0.385145,0.480377,0.140946,0.946253,0.379663,0.177787,0.592794,0.358477,0.755692,0.366734,0.208613,1.23455,0.468292,0.665569,0.0383601
}}
}}

Revision as of 18:01, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr10:98378743..98378761,+p@chr10:98378743..98378761
+
Mm9::chr11:76322923..76322937,-p13@Abr
Mm9::chr11:78511087..78511107,-p6@Nlk
Mm9::chr12:38607250..38607266,+p14@Dgkb
Mm9::chr12:83271300..83271328,+p6@Sipa1l1
Mm9::chr13:16072231..16072236,-p@chr13:16072231..16072236
-
Mm9::chr14:70476975..70476997,+p2@Egr3
Mm9::chr15:16658662..16658676,+p@chr15:16658662..16658676
+
Mm9::chr15:98634231..98634235,-p@chr15:98634231..98634235
-
Mm9::chr15:98638321..98638339,-p1@Ddn
Mm9::chr15:98638341..98638363,-p2@Ddn
Mm9::chr15:98638371..98638387,-p3@Ddn
Mm9::chr15:98638393..98638407,-p4@Ddn
Mm9::chr15:98638426..98638433,-p6@Ddn
Mm9::chr16:9995601..9995612,-p@chr16:9995601..9995612
-
Mm9::chr17:71110733..71110746,-p@chr17:71110733..71110746
-
Mm9::chr18:61145396..61145407,+p@chr18:61145396..61145407
+
Mm9::chr19:45890497..45890566,-p1@Kcnip2
Mm9::chr19:45890729..45890742,-p3@Kcnip2
Mm9::chr1:156731300..156731309,-p@chr1:156731300..156731309
-
Mm9::chr1:182413541..182413616,-p1@6330403A02Rik
Mm9::chr2:102498385..102498396,+p16@Slc1a2
Mm9::chr2:12933299..12933313,-p1@C1ql3
Mm9::chr2:61986030..61986033,+p10@Slc4a10
Mm9::chr2:80421664..80421676,-p11@Nckap1
Mm9::chr3:136333533..136333547,+p8@Ppp3ca
Mm9::chr3:67868320..67868329,+p16@Schip1
Mm9::chr4:128798478..128798559,-p1@Hpca
Mm9::chr4:17563333..17563339,-p@chr4:17563333..17563339
-
Mm9::chr5:129325928..129325957,-p7@Rimbp2
Mm9::chr5:24565260..24565271,-p@chr5:24565260..24565271
-
Mm9::chr5:73771769..73771785,+p@chr5:73771769..73771785
+
Mm9::chr5:73771821..73771831,+p@chr5:73771821..73771831
+
Mm9::chr6:96066965..96066998,-p@chr6:96066965..96066998
-
Mm9::chr7:125587063..125587085,-p4@Syt17
Mm9::chr7:68708036..68708039,-p@chr7:68708036..68708039
-


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


no results for this coexpression

Relative expression of the co-expression cluster over median <br>Analyst:





Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br><br>


Uber Anatomy
Ontology termp-valuen
regional part of nervous system1.08e-3054
neural tube9.46e-3052
neural rod9.46e-3052
future spinal cord9.46e-3052
neural keel9.46e-3052
gray matter9.15e-2834
brain4.46e-2547
future brain4.46e-2547
central nervous system3.44e-2473
regional part of brain1.93e-2346
nervous system2.52e-2375
brain grey matter6.88e-2329
regional part of telencephalon6.88e-2329
telencephalon6.88e-2329
neurectoderm9.80e-2364
neural plate9.80e-2364
presumptive neural plate9.80e-2364
anterior neural tube2.80e-2140
occipital lobe4.75e-2110
visual cortex4.75e-2110
neocortex4.75e-2110
regional part of forebrain7.82e-2039
forebrain7.82e-2039
future forebrain7.82e-2039
regional part of cerebral cortex2.35e-1917
ecto-epithelium5.42e-1973
cerebral cortex8.72e-1821
cerebral hemisphere8.72e-1821
pallium8.72e-1821
ectoderm-derived structure1.09e-1695
ectoderm1.09e-1695
presumptive ectoderm1.09e-1695
pre-chordal neural plate2.74e-1649
structure with developmental contribution from neural crest1.64e-1392
tube1.76e-09114
posterior neural tube7.27e-0912
chordal neural plate7.27e-0912
anatomical conduit2.20e-08122
regional part of midbrain2.22e-084
midbrain2.22e-084
presumptive midbrain2.22e-084
midbrain neural tube2.22e-084
spinal cord1.29e-076
dorsal region element1.29e-076
dorsum1.29e-076


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}